We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.43B
AUM Growth
+$140M
Cap. Flow
+$62.6M
Cap. Flow %
4.36%
Top 10 Hldgs %
17.76%
Holding
218
New
47
Increased
72
Reduced
39
Closed
34

Top Buys

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$20.7M
2
TLIS
Talis Biomedical Corporation Common Stock
TLIS
+$18.3M
3
KALV
KalVista Pharmaceuticals
KALV
+$15.6M
4
TIL icon
Instil Bio
TIL
+$14.1M
5
XOM icon
ExxonMobil
XOM
+$13.2M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$25.2M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$23.6M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$13.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$13.5M
5
CZR icon
Caesars Entertainment
CZR
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.74%
2 Technology 10.12%
3 Industrials 8.37%
4 Financials 7.73%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
176
iShares Russell 2000 ETF
IWM
$81.9B
– –
-6,822
Closed -$1.34M
JACK icon
177
Jack in the Box
JACK
$335M
– –
-78,671
Closed -$7.3M
LULU icon
178
lululemon athletica
LULU
$14.6B
– –
-1,866
Closed -$649K
MA icon
179
Mastercard
MA
$493B
– –
-11,066
Closed -$3.95M
MRTN icon
180
Marten Transport
MRTN
$1.22B
– –
-79,498
Closed -$1.37M
PLMR icon
181
Palomar
PLMR
$3.45B
– –
-42,192
Closed -$3.75M
PNR icon
182
Pentair
PNR
$11B
– –
-13,320
Closed -$707K
SRPT icon
183
Sarepta Therapeutics
SRPT
$1.77B
– –
-78,970
Closed -$13.5M
TDOC icon
184
Teladoc Health
TDOC
$1.3B
– –
-126,104
Closed -$25.2M
UTZ icon
185
Utz Brands
UTZ
$1.25B
– –
-21,156
Closed -$467K
V icon
186
Visa
V
$677B
– –
-2,801
Closed -$613K
VERX icon
187
Vertex
VERX
$1.94B
– –
-68,537
Closed -$2.39M
VITL icon
188
Vital Farms
VITL
$525M
– –
-73,476
Closed -$1.86M
PTVE
189
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
– –
-329,472
Closed -$5.98M
SILK
190
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-219,483
Closed -$13.8M
AYX
191
DELISTED
Alteryx Inc
AYX
– –
-31,104
Closed -$3.79M
KSU
192
DELISTED
Kansas City Southern
KSU
– –
-11,670
Closed -$2.38M
MDLA
193
DELISTED
Medallia, Inc.
MDLA
– –
-243,121
Closed -$8.08M
STAY
194
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-395,143
Closed -$5.85M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Nicholas Investment Partners held 218 positions worth $1.43B, up 11% from $1.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $62.6M of net new capital in Q1 2021, opening 47 new positions and adding to 72 existing holdings. Its largest new stake was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Caesars Entertainment, an estimated $10.5M trimmed.

  • Nicholas Investment Partners's largest Q1 2021 buy was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.
  • Nicholas Investment Partners added most to 908 Devices in Q1 2021, an estimated $12.3M increase.
  • Nicholas Investment Partners's biggest Q1 2021 reduction was Caesars Entertainment, cutting an estimated $10.5M.
  • Nicholas Investment Partners fully exited Teladoc Health in Q1 2021, selling an estimated $25.2M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.43B portfolio in Q1 2021.
  • Nicholas Investment Partners opened 47 new positions and closed 34 in Q1 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.43B.

Based on Nicholas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.